The pace of change has accelerated in recent months as companies across the globe try to figure out new ways of operating under pandemic-mandated restrictions. Rules and regulations designed to cautiously assess the efficacy of drugs and treatments are increasingly viewed with skepticism and impatience. Processes of testing and approval that used to take years are suddenly accelerated and expected to yield results in months. The willingness to embrace digital technology is a hallmark of today’s new streamlined, fast-tracked FDA. Meanwhile, Germany floats a controversial Nutri-Score labeling system, with scientists pushing for a sustainable designation to be added, further fragmenting the single market. New Future of Food companies like Climax Foods propose to combat the next global health crisis by re-engineering the food chain. Let’s hope that rushing forward doesn’t set us back in the long run.

Read More:

https://www.biospace.com/article/how-covid-19-is-changing-fda-approval-and-clearance-processes/

https://www.oliveoiltimes.com/briefs/scientists-want-a-climate-label-added-to-europes-nuti-score/85314

https://www.businesswire.com/news/home/20200901005441/en/Climax-Foods-Raises-7.5-Million-Seed-Transform